2025
SJR Q1
JCR Q2 · 4,6
203 matched articles
SCIE
Journal detail
Diabetes Research and Clinical Practice
- Publisher
- Elsevier Ireland Ltd
- Country
- Ireland · Western Europe
- Type
- journal
- ISSN
-
0168822718728227
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,69
- Quartile Q1
- H-Index 155
- Cites/doc 4,3
- Docs (3y) 1.130
- Cites (3y) 5.893
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,6
- 5Y JIF 6,2
- JCI 1,57
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Endocrinology Q1
- Endocrinology, Diabetes and Metabolism Q1
- Internal Medicine Q1
- Medicine (miscellaneous) Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Endocrinology & Metabolism
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,69 | 4,6 | 6,2 | 1,57 | Q1 | 155 |
| 2024 | Q1 | Q1 | 1,537 | 7,4 | 6 | 1,45 | Q1 | 146 |
| 2023 | Q1 | Q1 | 1,34 | 6,1 | 5,9 | 1,57 | Q1 | 146 |
| 2022 | Q1 | Q2 | 1,634 | 5,1 | 6,1 | 1,18 | Q1 | 146 |
| 2021 | Q1 | Q1 | 1,677 | 8,2 | 6,6 | 1,29 | Q1 | 146 |
| 2020 | Q1 | Q1 | 1,605 | 5,6 | 4,9 | 1,1 | Q1 | 146 |
| 2019 | Q1 | Q1 | 1,402 | 4,2 | 4 | 0,96 | Q2 | 146 |
| 2018 | — | Q2 | — | 3,2 | 3,6 | 0,78 | Q2 | — |
| 2017 | Q1 | Q3 | 1,538 | 2,5 | 3,2 | 0,82 | Q2 | 146 |
| 2016 | Q1 | Q2 | 1,531 | 3,6 | 3,3 | — | — | 146 |
| 2015 | Q1 | Q2 | 1,352 | 3 | 3,4 | — | — | 146 |
| 2014 | Q1 | Q3 | 1,232 | 2,5 | 3,1 | — | — | 146 |
| 2013 | Q1 | Q3 | 1,289 | 2,5 | 2,9 | — | — | 146 |
| 2012 | Q1 | Q2 | 1,034 | 2,7 | 2,6 | — | — | 146 |
| 2011 | Q1 | Q2 | 1,013 | 2,8 | 2,4 | — | — | 146 |
| 2010 | Q1 | Q3 | 0,974 | 2,1 | 2,2 | — | — | 146 |
| 2009 | — | Q3 | — | 2,2 | 2,1 | — | — | — |
| 2008 | — | Q4 | — | 1,9 | 2,1 | — | — | — |
| 2007 | — | Q3 | — | 1,8 | 2,1 | — | — | — |
| 2006 | — | Q3 | — | 1,8 | — | — | — | — |
| 2005 | — | Q4 | — | 1,2 | — | — | — | — |
| 2004 | — | Q3 | — | 1,7 | — | — | — | — |
| 2003 | — | Q3 | — | 1,7 | — | — | — | — |
| 2002 | — | Q3 | — | 1,3 | — | — | — | — |
| 2001 | — | Q3 | — | 1,6 | — | — | — | — |
| 2000 | — | Q3 | — | 1 | — | — | — | — |
| 1999 | — | Q4 | — | 0,7 | — | — | — | — |
| 1998 | — | Q4 | — | 0,6 | — | — | — | — |
| 1997 | — | Q3 | — | 1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 55/198 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 18/193 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 21/186 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 37/145 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 20/146 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 31/146 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 34/143 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 69/145 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 90/142 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 49/138 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 63/133 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 73/128 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 67/124 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 58/122 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 56/122 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 80/116 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 66/105 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 73/93 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 69/92 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 63/93 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 71/89 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 56/87 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 55/88 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 59/88 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 51/90 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 66/89 |
| 1999 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 70/85 |
| 1998 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 75/83 |
| 1997 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 55/81 |